CompaniesSilicon Biosystems

Silicon Biosystems

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

5,542

By Status

ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
NCT00578240
Hover over trial bars to see details

Recent Trials

NCT06833853Lead Sponsor
A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
N/ANot yet recruiting
187 participants
Started: Oct 15, 2025 · Completed: Mar 1, 2029
NCT05662345Lead Sponsor
ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
N/AActive, not recruiting
65 participants
Started: Dec 12, 2022 · Completed: Oct 30, 2026
NCT00578240Collaborator
Molecular Studies and Clinical Correlations in Human Prostatic Disease
N/AActive, not recruiting
5,290 participants
Started: Apr 30, 1990 · Completed: Dec 31, 2026
Related Companies
Menarini
acquired